VIRMA and prostate adenocarcinoma: Supplementary Figure 2A illustrates the connection between KIAA1429 expression and DFI in patients with KIRP (HR=7.21, p=9.1e-5), prostate adenocarcinoma (PRAD, HR=3.76, p=3.5e-3), brain lower grade glioma (LGG, HR=2.67, p=4.4e-3), LIHC (HR=1.29, p=0.02), and COAD (HR=3.5, p=0.04).